November 18-19, 2026
Santa Clara Convention Center
Silicon Valley, CA
November 18-19, 2026
Santa Clara Convention Center
Silicon Valley, CA
#MEDeviceSiliconValley
MEDevice Silicon Valley’s 2026 Keynotes open each day with forward-looking perspectives from leading voices in medical device development and innovation. Each session is built around a specific, timely topic that engineers, R&D leaders, and MedTech professionals need to understand today to stay ahead of what comes next.
Explore how nanophotonics and AI are turning light into a new kind of medical measurement, readying biology from single protein molecules to cell states to real-time clinical decisions. Learn what it takes to move these platforms from the lab to reproduce, manufacturable medical devices.
Discover how early-stage medtech founders are redefining the path from invention to scale—moving beyond "raise, spend, raise bigger" to build flexibility, aligned partnerships, and strategic resilience in an unforgiving funding landscape. Learn what operators need to understand about avoiding startup purgatory and building companies built to last.
Wednesday, November 18, 2026 | 9:15 – 10:15 a.m.
Medical devices are moving beyond passive measurement toward direct, information-rich interfaces with biology. Stanford’s Jennifer Dionne shows how her team combines semiconductor nanophotonic chips, Rama spectroscopy, and machine learning to read biology from single molecules to living animals, and what it takes to turn these platforms into manufacturable devices that fit clinical workflows.
Get an early look at how nanophotonic chips and AI are moving devices from passive measurement to direct readings of biology, and what the shift means for the products you’ll design next.
Learn where this work is heading in the clinic, from treatment-response monitoring to real-time organ viability checks during transplants, and spot where it could fit in your pipeline.
Hear the hurdles that decide whether a lab breakthrough becomes a real device: reproducibility, data interpretation, system integration, and workflow.
Leave with a clearer sense of which of these technologies to watch, and what it will take to bring them into products that are smaller, faster, and more biologically informative.
Thursday, November 19, 2026 | 9:15 – 10:15 a.m.
The hardest question for early-stage medtech isn't whether you can build a novel device—it's whether you can survive long enough to prove it. Drawing from FastWave Medical's experience, Scott Nelson shares how founder-led companies can build flexibility, preserve optionality, and use aligned partnerships to avoid startup purgatory. Learn a constructive operator's framework for building medtech companies resilient enough to scale.
Learn how to structure capital raises and partnerships that preserve optionality rather than locking you into rigid growth trajectories.
Understand how dependency on narrow funding sources can threaten survival and discover strategies to diversify your capital base.
Replace the "raise, spend, raise bigger" playbook with a sustainable approach that positions your company to scale through uncertainty and disruption.
Develop aligned partnerships that help you move from prototype to market validation without burning through runway.